Chung et al., 2021
Featured review: Cellular and pathological heterogeneity of primary tauopathies
Dah-eun Chloe Chung, ... & Dennis W. Dickson
Bai et al. 2021
Featured Research: The TGFβ/Notch axis facilitates Müller cell-to-epithelial transition to ultimately form a chronic glial scar
Federica Maria Conedera, ... & Volker Enzmann
Featured Research: Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy
Silvia Bono, Marco Feligioni & Massimo Corbo
Articles
-
-
Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains
-
Dynamic changes of CSF sPDGFRβ during ageing and AD progression and associations with CSF ATN biomarkers
-
Edaravone activates the GDNF/RET neurotrophic signaling pathway and protects mRNA-induced motor neurons from iPS cells
-
A novel H129-based anterograde monosynaptic tracer exhibits features of strong labeling intensity, high tracing efficiency, and reduced retrograde labeling
-
The neuropathological diagnosis of Alzheimer’s disease
-
The Alzheimer's disease β-secretase enzyme, BACE1
-
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
-
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
-
α-Synuclein and neuronal cell death
Editor highlights
Alzheimer's Disease: Challenges for the next decade
Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease.
Edited by Guojun Bu, Alison Goate and Todd Golde, reviews will continue to publish throughout 2021. The collection can be read here.
News from Alzforum
-
Stroke Severity, Recurrence Increase Dementia Risk
28 January 2022
-
Survey of Tau Partners Highlights Synaptic, Mitochondrial Roles
27 January 2022
-
Contact the Managing Editorial Team
Hongmei Li - Hongmei.Li@MolecularNeurodegeneration.org
Lucy Job - Lucy.Job@MolecularNeurodegeneration.org
About Us
The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Follow
Annual Journal Metrics
-
Speed
58 days to first decision for reviewed manuscripts only
31 days to first decision for all manuscripts
153 days from submission to acceptance
28 days from acceptance to publication
Citation Impact
14.195 - 2-year Impact Factor
11.684 - 5-year Impact Factor
2.172 - Source Normalized Impact per Paper (SNIP)
5.565 - SCImago Journal Rank (SJR)
Usage
770,533 downloads
723 Altmetric mentions